Skip to main content

Table 1 Baseline demographic and clinical characteristics in men

From: Gender differences in the relationship between serum uric acid and the long-term prognosis in heart failure: a nationwide study

 

All (N=897)

Tertile 1 (N=306)

Tertile 2 (N=299)

Tertile 3 (N=292)

Uric acid (mg/dL)

6.6 (5.4-7.9)

<5.9

5.9-7.4

>7.4

Age, years

70 (61-78)

70 (60-78)

68 (60-77)

70 (61-78)

Body mass index, kg/m2

29.6 (25.9-34.0)

28.1 (24.2-32.3)

30.4 (26.4-34.7) †

30.5 (26.4-35.1) †

Systolic BP, mmHg

128 (115-142)

128 (116-142)

128 (115-142)

126 (113-144)

Diastolic BP, mmHg

68 (58-78)

69 (58-77)

70 (60-78)

66 (58-77)

Heart rate, bpm

70 (62-78)

70 (60-76)

70 (60-78)

69 (62-78)

Race, n (%)

    

Non-Hispanic White

522 (58.2)

173 (56.5)

178 (59.5)

171 (58.6)

No-Hispanic Black

179 (20.0)

54 (17.6)

47 (15.7)

78 (26.7) †‡

Mexican American

93 (10.4)

37 (12.1)

38 (12.7)

18 (6.2) †‡

Other

103 (11.4)

42 (13.8)

36 (12.1)

25 (8.5) †

History of smoking, n (%)

643 (71.7)

215 (70.3)

218 (72.9)

210 (71.9)

History of drinking, n (%)

691 (77.0)

227 (74.2)

241 (80.6)

223 (76.4)

Hypertension, n (%)

721 (80.4)

231 (75.5)

241 (80.6)

249 (85.3) †

Diabetes mellitus, n (%)

387 (43.1)

134 (43.8)

123 (41.1)

130 (44.5)

Coronary heart disease, n (%)

432 (48.2)

148 (48.4)

153 (51.2)

131 (44.9)

Stroke, n (%)

184 (20.5)

72 (23.5)

54 (18.1)

58 (19.9)

Laboratory tests

    

WBC, 103/uL

7.3 (6.1-8.8)

7.3 (6.0-8.5)

7.3 (6.0-8.8)

7.3 (6.1-8.9)

Hemoglobin, g/dL

14.0 (12.5-15.0)

14.1 (12.6-15.1)

14.1 (12.8-15.0)

13.7 (12.1-14.9) ‡

Albumin, g/L

41.0 (39.0-43.0)

41.0 (38.0-44.0)

41.0 (39.0-43.0)

41.0 (39.0-43.0)

HbA1c, %

5.9 (5.5-6.6)

5.9 (5.4-6.7)

5.9 (5.5-6.5)

6.0 (5.5-6.6)

Total cholesterol, mmol/L

4.3 (3.6-5.1)

4.3 (3.6-5.0)

4.4 (3.6-5.2)

4.4 (3.6-5.3)

Triglycerides, mg/dL

135.0 (91.5-200.5)

128.0 (84.0-192.5)

143.0 (97.0-202.0)

139.0 (95.0-205.8)

Serum glucose, mg/dL

102.0 (92.0-128.0)

102.0 (91.0-135.0)

100.0 (91.0-124.0)

104.0 (93.0-125.0)

eGFR, mL/min/1.73m2

67.5 (50.2-88.2)

76.8 (59.3-94.7)

69.5 (53.3-88.8) †

55.8 (40.4-71.2) †‡

Serum sodium, mmol/L

139.0 (138.0-141.0)

139.0 (137.0-141.0)

139.0 (138.0-141.0)

139.0 (138.0-141.0)

Serum potassium, mmol/L

4.2 (3.9-4.5)

4.2 (4.0-4.5)

4.1 (3.9-4.4) †

4.2 (3.9-4.5) ‡

Serum chloride, mmol/L

103.0 (100.0-105.0)

103.0 (100.0-105.0)

103.0 (101.0-105.0)

102.0 (100.0-105.0)

Medication

    

ACEI/ARB, n (%)

504 (56.2)

145 (47.4)

167 (55.9) †

192 (65.8) †‡

Beta blockers, n (%)

534 (59.5)

169 (55.2)

171 (57.2)

194 (66.4) †‡

MRA, n (%)

64 (7.1)

9 (2.9)

19 (6.4) †

36 (12.3) †‡

Diuretics, n (%)

431 (48.0)

89 (29.1)

135 (45.2) †

207 (70.9) †‡

Urate-lowering agents, n (%)

78 (8.7)

37 (12.1)

27 (9.0)

14 (4.8) †‡

  1. Values are presented as median (interquartile range), or n (%). For P-value, † indicates p value < 0.05 versus Tertile 1, ‡ indicates p value < 0.05 versus Tertile 2
  2. Abbreviations: ACE-I, angiotensin-converting inhibitor; ARB, angiotensin II receptor blocker; BP, blood pressure; eGFR, the rate of estimated glomerular filtration rate; Hb1Ac, hemoglobin A1c; MRA, mineralocorticoid-receptor antagonist; WBC, white blood cells